Table 2.
Variable | (n = 38) | PFS, months | Univariablep value | OS, months | Univariablep value |
---|---|---|---|---|---|
Gender | |||||
Male | 15 (40) | 19 | 0.794 | 62 | 0.522 |
Female | 24 (60) | 10 | 35 | ||
Age | |||||
<60 years | 23 (61) | 19 | 0.057 | 62 | 0.196 |
≥ 60 years | 15 (29) | 9 | 35 | ||
Interval primary tumor – hepatic metastases | |||||
Synchronous | 11 (28) | 5 | 0.021 | 40 | 0.508 |
Metachronous | 23 (59) | 19 | 20 | ||
Number of hepatic metastases | |||||
Solitary | 20 (51) | 10 | 0.367 | 62 | 0.360 |
Multiple | 14 (36) | 16 | 46 | ||
Distribution metastases | |||||
Unilobar | 28 (74) | 13 | 0.684 | 56 | 0.960 |
Bilobar | 8 (21) | 18 | 20 | ||
Resection status | |||||
RO or R1 | 21 (55) | 16 | 0.869 | 77 | 0.192 |
R2 | 15 (39) | 10 | 20 | ||
Type of resection | |||||
Minor | 24 (63) | 10 | 0.854 | 18 | 0.321 |
Major | 13 (34) | 16 | 56 | ||
Primary tumour site | |||||
Intra-abdominal | 22 (58) | 9 | 0.364 | 19 | 0.099 |
Extra-abdominal | 16 (42) | 17 | Not reached |
PFS, progression-free survival; OS, overall survival.